# Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India

> **NCT01292018** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 5400 (actual)

## Conditions studied

- Dyslipidemia
- Type 2 Diabetes Mellitus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01292018
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** —
- **Final completion:** 2012-02
- **Target enrollment:** 5400 (ACTUAL)
- **Last updated:** 2013-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01292018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01292018, "Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01292018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*